| Size | Price | Stock | Qty |
|---|---|---|---|
| 5mg |
|
||
| 10mg |
|
||
| 25mg |
|
||
| 50mg |
|
||
| 100mg |
|
||
| 250mg |
|
||
| 500mg |
|
||
| Other Sizes |
|
Purity: ≥98%
kb NB 142-70 (kb NB142-70; kb NB-142-70) is a novel, potent and selective PKD (protein kinase D) inhibitor with anticancer activity. With IC50 values of 28.3, 58.7, and 53.2 nM for PKD1, PKD2, and PKD3, respectively, it prevents PKD. Potential antitumor activity exists for kb NB 142-70. Numerous cellular functions and pathological conditions, including cancer, have been linked to protein kinase D (PKD). Due to the lack of a strong and focused inhibitor, it is still challenging to therapeutically target PKD and analyze PKD-mediated cellular responses. Intestinal epithelial cell migration brought on by wounds is stopped by kb NB 142-70
| Targets |
PKD1 (IC50 = 28.3 nM); PKD3 (IC50 = 53.2 nM); PKD2 (IC50 = 58.7 nM)
|
|---|---|
| ln Vitro |
kb NB 142-70 is a potent PKD inhibitor, with IC50s of 28.3, 58.7 and 53.2 nM for PKD1, PKD2, and PKD3, respectively. In LNCaP cells, kb NB 142-70 also inhibits PKD1 Ser916 phosphorylation (IC50, 2.2 ± 0.6 μM).
Furthermore, kb NB 142-70 has an EC50 of 8.025 μM and is cytotoxic to PC3 cells[1]. In IEC-18 cells, kb NB 142-70 (0–5 μM) inhibits ANG II-induced phosphorylation of HDAC4 at Ser246 and Ser632, HDAC5 at Ser259 and Ser498, and HDAC7 at Ser155. Additionally, kb NB 142-70 (3.5 μM) inhibits the phosphorylation of HDAC4, HDAC5, and HDAC7 in IEC-18 cells stimulated with ANG II for 0-240 min or with vasopressin, lysophosphatidic acid (LPA), or phorbol 12,13-dibutyrate (PDBu)[2]. |
| Cell Assay |
PC3 cells are treated with kb NB 142-70 at a concentration of 10 μM for 48 h, followed by an overnight fixation in 70% ice-cold ethanol and labeling with propidium iodide. A FACScan Benchtop Cytometer is used to analyze the labeled cells[1].
|
| References |
|
| Molecular Formula |
C11H9NO2S2
|
|---|---|
| Molecular Weight |
251.3247
|
| Exact Mass |
251.007
|
| Elemental Analysis |
C, 52.57; H, 3.61; N, 5.57; O, 12.73; S, 25.51
|
| CAS # |
1233533-04-4
|
| Related CAS # |
1233533-04-4
|
| PubChem CID |
45258277
|
| Appearance |
White to gray solid powder
|
| Density |
1.5±0.1 g/cm3
|
| Boiling Point |
601.9±55.0 °C at 760 mmHg
|
| Flash Point |
317.8±31.5 °C
|
| Vapour Pressure |
0.0±1.8 mmHg at 25°C
|
| Index of Refraction |
1.746
|
| LogP |
2.39
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
4
|
| Rotatable Bond Count |
0
|
| Heavy Atom Count |
16
|
| Complexity |
300
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
S1C([H])([H])C([H])([H])N([H])C(C2=C1C1C([H])=C(C([H])=C([H])C=1S2)O[H])=O
|
| InChi Key |
DHUAGGSHTKPOHU-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C11H9NO2S2/c13-6-1-2-8-7(5-6)9-10(16-8)11(14)12-3-4-15-9/h1-2,5,13H,3-4H2,(H,12,14)
|
| Chemical Name |
9-hydroxy-3,4-dihydro-2H-[1]benzothiolo[2,3-f][1,4]thiazepin-5-one
|
| Synonyms |
kb NB 142-70; kb NB 142-70; kb NB-142-70; kb NB142-70; kb NB 142 70
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO: ~46.7 mg/mL (~185.7 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 3.5 mg/mL (13.93 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 35.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 2: ≥ 3.5 mg/mL (13.93 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 35.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.9790 mL | 19.8950 mL | 39.7899 mL | |
| 5 mM | 0.7958 mL | 3.9790 mL | 7.9580 mL | |
| 10 mM | 0.3979 mL | 1.9895 mL | 3.9790 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
 Chemical structures and SAR of CID755673 and its analogs.BMC Chem Biol.2010 May 5;10:5. |
|---|
 Selectivity of the CID755673 analogs.BMC Chem Biol.2010 May 5;10:5. |
 Cytotoxic effects of the CID755673 analogs in PC3 cells.BMC Chem Biol.2010 May 5;10:5. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
COA